person · Reporting owner

MURRAY JAMES E

Disclosed activity across 3 companies

Tapewire entity: 111888
SEC CIK: 0001018658

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CENTENE CORPCNC · Entity 3133	EVP, Chief Operating Officer	June 23, 2023	June 27, 2023
MAGELLAN HEALTH INCMGLN · Entity 131790	President and COO	January 02, 2022	January 04, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CENTENE CORP

Report date June 23, 2023 · Filed June 27, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2023-06-23	Direct	347.209	Reported balance After 2023-06-23 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-06-23 · Grant · Acquired 38.865 · Balance 347.209 F2: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3: The phantom stock was acquired by Mr. Murray through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Murray's termination with the Company or on such other date Mr. Murray may elect.
Common StockSEC Table I · non-derivative	Direct	202,853	Reported balance Holding disclosure · report date 2023-06-23 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 202,853 F1: Ownership includes 166,676 shares of restricted stock subject to vesting requirements.
Common StockSEC Table I · non-derivative	IndirectBy trust	30	Reported balance Holding disclosure · report date 2023-06-23 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 30
Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $63.31 · Expires 2030-01-02	Direct	30,683	Reported balance Holding disclosure · report date 2023-06-23 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 30,683

Filing footnotes · ownership attribution and instrument terms

F1: Ownership includes 166,676 shares of restricted stock subject to vesting requirements.

F2: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock.

F3: The phantom stock was acquired by Mr. Murray through regularly scheduled payroll contributions to the Company's deferred compensation plan.

F4: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Murray's termination with the Company or on such other date Mr. Murray may elect.

MAGELLAN HEALTH INC

Report date January 02, 2022 · Filed January 04, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	0	Ending reported balance After 2022-01-04 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2022-01-02 · Exercise / conversion · Acquired 3,262 · Balance 14,074 F1: This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F2: Not applicable. Row 2 · 2022-01-02 · Tax withholding · Disposed 871 · Balance 13,203 F3: Represents the portion of shares withheld by the Issuer in order to pay taxes. F4: Closing price on Nasdaq on December 31, 2021. Row 3 · 2022-01-04 · Disposition to issuer · Disposed 13,203 · Balance 0 F5: In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among the Issuer, Centene Corporation ("Centene") and Mayflower Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the "Merger Consideration").
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	3,262	Reported balance After 2022-01-02 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2022-01-02 · Exercise / conversion · Disposed 3,262 · Balance 3,262 F2: Not applicable. F1: This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F6: The remaining 3,262 Restricted Stock Units vest on January 2, 2023.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2022-01-04 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2022-01-04 · Disposition to issuer · Disposed 3,262 · Balance 0 F2: Not applicable. F8: These unvested restricted stock units previously granted by the Issuer on January 2, 2020, which provided for vesting on January 2, 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2022-01-04 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-01-04 · Disposition to issuer · Disposed 14,566 · Balance 0 F2: Not applicable. F9: These unvested restricted stock units previously granted by the Issuer on March 4, 2020, which provided for vesting in equal increments on each of March 4, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2022-01-04 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-01-04 · Disposition to issuer · Disposed 28,271 · Balance 0 F2: Not applicable. F10: These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $76.64 · Expires 2030-01-02	Direct	0	Reported balance After 2022-01-04 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-01-04 · Disposition to issuer · Disposed 25,346 · Balance 0 F7: These options previously granted on January 2, 2020, which provided for vesting in 3 equal installments, were disposed of in exchange for a number of options to purchase shares of Centene common stock and at an exercise price per share, in each case, as determined in accordance with the Merger Agreement. The remaining one-third vests on January 2, 2023.
Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2022-01-04 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-01-04 · Disposition to issuer · Disposed 14,006 · Balance 0 F2: Not applicable. F11: These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on January 2, 2020 were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.
Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2022-01-04 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-01-04 · Disposition to issuer · Disposed 18,206 · Balance 0 F2: Not applicable. F12: These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on March 4, 2020 were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.

F2: Not applicable.

F3: Represents the portion of shares withheld by the Issuer in order to pay taxes.

F4: Closing price on Nasdaq on December 31, 2021.

F5: In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among the Issuer, Centene Corporation ("Centene") and Mayflower Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the "Merger Consideration").

F6: The remaining 3,262 Restricted Stock Units vest on January 2, 2023.

F7: These options previously granted on January 2, 2020, which provided for vesting in 3 equal installments, were disposed of in exchange for a number of options to purchase shares of Centene common stock and at an exercise price per share, in each case, as determined in accordance with the Merger Agreement. The remaining one-third vests on January 2, 2023.

F8: These unvested restricted stock units previously granted by the Issuer on January 2, 2020, which provided for vesting on January 2, 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.

F9: These unvested restricted stock units previously granted by the Issuer on March 4, 2020, which provided for vesting in equal increments on each of March 4, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.

F10: These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.

F11: These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on January 2, 2020 were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.

F12: These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on March 4, 2020 were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

HUMANA INC

Report date March 30, 2017 · Filed April 03, 2017

Section 16 reporting ended · disclosed 2017-04-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Humana CommonSEC Table I · non-derivative	Direct	34,668	Reported balance After 2017-03-30 transaction · row 1 1 source row Row 1 · 2017-03-30 · Gift · Disposed 121 · Balance 34,668
Phantom Stock UnitsSEC Table II · derivative / convertible security	IndirectSee Footnote	205	Reported balance After 2017-03-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-03-31 · Other · Acquired 5 · Balance 205 F7: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.
Humana CommonSEC Table I · non-derivative	IndirectSee Footnote	2,940	Reported balance Holding disclosure · report date 2017-03-30 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 2,940 F6: Shares held in October 2015 GRAT.
Humana CommonSEC Table I · non-derivative	IndirectSee Footnote	29	Reported balance Holding disclosure · report date 2017-03-30 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 29 F1: Shares held for the benefit of reporting person as of February 28, 2017 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $164.65 · Expires 2022-02-24	Direct	10,846	Reported balance Holding disclosure · report date 2017-03-30 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 10,846 F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. F8: Any unvested equity will be cancelled as of March 31, 2017 per the Voluntary Release and Separation Agreement signed by Mr. Murray, as filed in the Company's 8-K.
OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $167.81 · Expires 2023-02-18	Direct	21,475	Reported balance Holding disclosure · report date 2017-03-30 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 21,475 F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. F8: Any unvested equity will be cancelled as of March 31, 2017 per the Voluntary Release and Separation Agreement signed by Mr. Murray, as filed in the Company's 8-K.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	4,768	Reported balance Holding disclosure · report date 2017-03-30 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 4,768 F4: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F8: Any unvested equity will be cancelled as of March 31, 2017 per the Voluntary Release and Separation Agreement signed by Mr. Murray, as filed in the Company's 8-K.

Filing footnotes · ownership attribution and instrument terms

F1: Shares held for the benefit of reporting person as of February 28, 2017 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).

F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.

F4: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

F6: Shares held in October 2015 GRAT.

F7: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F8: Any unvested equity will be cancelled as of March 31, 2017 per the Voluntary Release and Separation Agreement signed by Mr. Murray, as filed in the Company's 8-K.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionOptions · Derivative	10,737	$0.00 Strike: $167.81	$0.00	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · derivative · entry 18 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,475 Underlying: Humana Common · 10,737 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. F6 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionOptions · Derivative	10,846	$0.00 Strike: $164.65	$0.00	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · derivative · entry 17 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,692 Underlying: Humana Common · 10,846 shares Expires 2022-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionOptions · Derivative	24,584	$0.00 Strike: $102.16	$0.00	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · derivative · entry 16 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 24,584 shares Expires 2021-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	SaleHumana Common	16,000	$205.44	$3,287,072.00	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 14 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,838 F20 · price: Shares sold at a prices ranging from $204.67 to $205.94. F10 · ownership.nature: Shares held in Family Trust - Mr. Murray's spouse is the trustee and his family members are the beneficiaries. F16 · ownership.nature: Shares held in October 2015 GRAT. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	SaleHumana Common	6,522	$205.62	$1,341,060.16	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 13 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F19 · price: Shares sold at a prices ranging from $205.37 to $205.96. F2 · ownership.nature: Shares held in The Murray Family Partnership. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	SaleHumana Common	1,356	$205.62	$278,822.08	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 12 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F19 · price: Shares sold at a prices ranging from $205.37 to $205.96. F2 · ownership.nature: Shares held in The Murray Family Partnership. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	SaleHumana Common	3,983	$205.56	$818,741.50	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 11 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F18 · price: Shares sold at a prices ranging from $205.46 to $205.99. F1 · ownership.nature: Shares held by reporting person's spouse. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	SaleHumana Common	14,855	$205.48	$3,052,449.97	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 10 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 12,407 F17 · price: Shares sold at a prices ranging from $204.67 to $205.94. F12 · ownership.nature: Shares held in October 2016 GRAT. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	SaleHumana Common	25,143	$205.40	$5,164,296.77	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 9 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,789 F21 · price: Shares sold at a prices ranging from $204.75 to $206.00. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	SaleHumana Common	45,189	$205.09	$9,267,685.48	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 7 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,455 F14 · price: Shares sold at a prices ranging from $204.63 to $205.54. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Tax withholdingHumana Common	487	$205.33	$99,993.28	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 6 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,644 Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionHumana Common	10,737	$167.81	$1,801,722.29	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 5 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionHumana Common	10,846	$164.65	$1,785,739.67	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 4 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 21, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionHumana Common	24,584	$102.16	$2,511,378.52	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 3 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 18, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionRestricted Stock Units · Derivative	5,384	$0.00	$0.00	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · derivative · entry 19 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 5,384 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/14, 100% of the award is vesting on 02/18/17. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/14, 100% of the award is vesting on 02/18/17. Read SEC document
February 18, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Tax withholdingHumana Common	7,834	$205.33	$1,608,516.05	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 2 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,964 Read SEC document
February 18, 2017 Filed Feb 23, 2017 02:06 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionHumana Common	17,357	$0.00	$0.00	Disclosure SEC source: 0000049071-17-000038 · edgar.xml · nonDerivative · entry 1 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · shares: Includes both time based (5,384) and performance based (11,973) restricted stock units that vested on 2/18/17. Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:52 UTC	HUMANA INC HUM · Entity 1429	OtherPhantom Stock Units · Derivative	6	$171.06	$1,026.36	Disclosure SEC source: 0000049071-17-000010 · edgar.xml · derivative · entry 12 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,808 Underlying: Humana Common · 6 shares Expires not disclosed F11 · security: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. F11 · derivative.exercise_price: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. F11 · derivative.exercise_date: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. F11 · derivative.expiration_date: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. F11 · ownership.nature: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. Read SEC document
December 15, 2016 Filed Dec 19, 2016 19:53 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionRestriced Stock Units · Derivative	2,383	$0.00	$0.00	Disclosure SEC source: 0000049071-16-000198 · edgar.xml · derivative · entry 12 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,768 Underlying: Humana Common · 2,383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document
December 15, 2016 Filed Dec 19, 2016 19:53 UTC	HUMANA INC HUM · Entity 1429	Tax withholdingHumana Common	1,180	$206.60	$243,782.10	Disclosure SEC source: 0000049071-16-000198 · edgar.xml · nonDerivative · entry 2 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,441 Read SEC document
December 15, 2016 Filed Dec 19, 2016 19:53 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionHumana Common	2,383	$0.00	$0.00	Disclosure SEC source: 0000049071-16-000198 · edgar.xml · nonDerivative · entry 1 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 01, 2016 Filed Dec 2, 2016 22:36 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionOptions · Derivative	13,868	$0.00 Strike: $72.84	$0.00	Disclosure SEC source: 0000049071-16-000186 · edgar.xml · derivative · entry 10 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 13,868 shares Expires 2020-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to buy pursuant to Company's 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16. Read SEC document
December 01, 2016 Filed Dec 2, 2016 22:36 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionOptions · Derivative	15,121	$0.00 Strike: $88.65	$0.00	Disclosure SEC source: 0000049071-16-000186 · edgar.xml · derivative · entry 9 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 15,121 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to buy pursuant to Company's 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/23/12, vesting in three increments from 02/23/13 to 02/23/15. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/23/12, vesting in three increments from 02/23/13 to 02/23/15. Read SEC document
December 01, 2016 Filed Dec 2, 2016 22:36 UTC	HUMANA INC HUM · Entity 1429	Tax withholdingHumana Common	19,443	$214.17	$4,164,107.31	Disclosure SEC source: 0000049071-16-000186 · edgar.xml · nonDerivative · entry 3 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,238 Read SEC document
December 01, 2016 Filed Dec 2, 2016 22:36 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionHumana Common	13,868	$72.84	$1,010,145.12	Disclosure SEC source: 0000049071-16-000186 · edgar.xml · nonDerivative · entry 2 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 01, 2016 Filed Dec 2, 2016 22:36 UTC	HUMANA INC HUM · Entity 1429	Exercise / conversionHumana Common	15,121	$88.65	$1,340,438.85	Disclosure SEC source: 0000049071-16-000186 · edgar.xml · nonDerivative · entry 1 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 20, 2016 Filed Oct 20, 2016 20:26 UTC	HUMANA INC HUM · Entity 1429	GiftHumana Common	27,262	$0.00	$0.00	Disclosure SEC source: 0000049071-16-000179 · edgar.xml · nonDerivative · entry 2 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 27,262 F14 · ownership.nature: On October 18, 2016, 27,262 shares, indirectly owned by reporting person, were transferred from reporting person's GRAT to reporting person's total direct ownership. On October 20, 2016, reporting person formed a new GRAT and transferred the same number of shares to the new GRAT. While the form of ownership changed, the number of shares held by reporting person did not change. Read SEC document
October 20, 2016 Filed Oct 20, 2016 20:26 UTC	HUMANA INC HUM · Entity 1429	GiftHumana Common	27,262	$0.00	$0.00	Disclosure SEC source: 0000049071-16-000179 · edgar.xml · nonDerivative · entry 1 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,692 Read SEC document
September 30, 2016 Filed Oct 3, 2016 19:48 UTC	HUMANA INC HUM · Entity 1429	OtherPhantom Stock Units · Derivative	7	$172.55	$1,207.85	Disclosure SEC source: 0000049071-16-000175 · edgar.xml · derivative · entry 13 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,813 Underlying: Humana Common · 7 shares Expires not disclosed F13 · security: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of September 30, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F13 · derivative.exercise_price: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of September 30, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F14 · price: Transaction reported reflects shares acquired through quarterly allocation of dividend equivilents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of July 29, 2016. F13 · derivative.exercise_date: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of September 30, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F13 · derivative.expiration_date: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of September 30, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F13 · ownership.nature: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of September 30, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.